Aaron Cox
Director of Finance/CFO bei HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Aktive Positionen von Aaron Cox
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Director of Finance/CFO | 16.05.2022 | - |
| Human Resources Officer | 01.07.2017 | 01.11.2021 | |
| Corporate Officer/Principal | 01.11.2021 | 16.05.2022 |
Karriereverlauf von Aaron Cox
Ehemalige bekannte Positionen von Aaron Cox
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
BMO Capital Markets Corp.
 BMO Capital Markets Corp. Investment ManagersFinance BMO Capital Markets Corp. (BMOCMC) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 1817 and is a direct, wholly-owned subsidiary of BMO Financial Corp., which is wholly-owned by Bank of Montreal (TSE: BMO, NYSE: BMO), a Canadian chartered bank. BMOCMC provides investment advisory and portfolio management services to institutional clients only. | Corporate Officer/Principal | - | - |
Ausbildung von Aaron Cox
| University of Notre Dame | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
| Irland | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
| Human Resources Officer | 1 |
Sektoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
BMO Capital Markets Corp.
BMO Capital Markets Corp. Investment ManagersFinance BMO Capital Markets Corp. (BMOCMC) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 1817 and is a direct, wholly-owned subsidiary of BMO Financial Corp., which is wholly-owned by Bank of Montreal (TSE: BMO, NYSE: BMO), a Canadian chartered bank. BMOCMC provides investment advisory and portfolio management services to institutional clients only. | Finance |
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
